Overview
EnteroBiotix (“EBX”) is a clinical-stage Microbiome biotech focused on developing therapeutics for Hepatic Encephalopathy (“HE”) and Graft vs. Host Disease (“GvHD”). EBX has a GMP-grade manufacturing facility and was approved by the Medicines and Healthcare products Regulatory Agency (“MHRA”).
Visit Site